CollPlant Biotechnologies Ltd — Form SCHEDULE 13D/A
Filed July 31, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
This is an amended Schedule 13D/A filed on 31 July 2026 by Lilian S. Loewenbaum regarding beneficial ownership in CollPlant Biotechnologies Ltd (Israeli biotech, ~$10.8M assets). The filing stub does not contain substantive amendment details—no share counts, ownership percentages, transaction amounts, or specific changes are disclosed in the provided document text.
Why this rating
Document is a procedural amendment filing; substantive disclosure content not provided. Insufficient data to assess materiality or business impact.
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.